tiprankstipranks

Thomas Schuetz Insider Profile

25 Followers
Thomas Schuetz, CEO, Director at Compass Therapeutics, holds 6.60M shares in Compass Therapeutics (Ticker: CMPX), holds 0.00 shares in Audentes Therapeutics (Ticker: ~BOLD), holds 3.96K shares in Relypsa Inc (Ticker: RLYP).
tipranks
Thomas Schuetz

Thomas Schuetz
Compass Therapeutics (CMPX)
CEO, Director

Ranked #69,451 out of 108,575 Corporate Insiders

Profitable Transactions

45%
10 out of 22 Profitable Transactions

Average Return

-3.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$16M
100.00%
A breakdown of Thomas Schuetz's holdings

Insider Roles

Compass Therapeutics
(CMPX)
CEO, Director
Roles that Thomas Schuetz holds in companies

Most Profitable Insider Trade

Stock:
Compass Therapeutics
(CMPX)
Rating:Informative Buy
Date:May 10, 2022 - May 10, 2023
Return:+105.40%
The most profitable trade made by Thomas Schuetz

Thomas Schuetz's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Compass Therapeutics
Feb 10, 2026
CEO, Director
Uninformative Sell
239.20K
$15.58M
RLYP
Relypsa Inc
Jun 23, 2016
Uninformative Buy
$126.74K
~BOLD
Audentes Therapeutics
Jan 15, 2020
Uninformative Sell
5.38M
$0.00
List of latest transactions for each holding click on a transaction to see Thomas Schuetz's performance on stock

Thomas Schuetz insider profile FAQ

What is the percentage of profitable transactions made by Thomas Schuetz?
The percentage of profitable transactions made by Thomas Schuetz is 45%.
    What is the average return per transaction made by Thomas Schuetz?
    The average return per transaction made by Thomas Schuetz is -3.60%.
      What stocks does Thomas Schuetz hold?
      Thomas Schuetz holds: CMPX, RLYP, ~BOLD stocks.
        What was Thomas Schuetz’s latest transaction?
        Thomas Schuetz latest transaction was an Uninformative Sell of $239.20K.
          What was Thomas Schuetz's most profitable transaction?
          Thomas Schuetz’s most profitable transaction was an Informative Buy of CMPX stock on May 10, 2022. The return on the trade was 105.40%.
            What is Thomas Schuetz's role in Compass Therapeutics?
            Thomas Schuetz's role in Compass Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.